Call Us: 269-430-7966
Call Us: 269-430-7966
At Brain Treatment Center Michigan, patient care is guided by a collaborative team of physicians and neuroscience professionals experienced in EEG-guided neuromodulation.
Every treatment plan is informed by objective brainwave data, detailed clinical history, and physician oversight to ensure care is personalized, appropriate, and medically responsible.
MeRT® (Magnetic e-Resonance Therapy) is a form of EEG-guided repetitive transcranial magnetic stimulation (rTMS). Treatment planning begins with quantitative EEG (qEEG) testing, which evaluates brainwave patterns and connectivity. This data is combined with clinical information and reviewed using a patented analytical methodology developed by Wave Neuroscience®, the innovators of MeRT technology.
Each treatment protocol is individually designed and reviewed by a licensed physician or neurosurgeon before implementation. This process ensures strict adherence to medical standards and alignment with each patient’s unique neurophysiology.
Dr. Ramona Wallace is a board-certified Family Medicine physician and Functional Medicine practitioner with more than 30 years of clinical experience.
She serves as Medical Director for Brain Treatment Center Michigan and is trained in MeRT® (Magnetic e-Resonance Therapy).
Her work integrates conventional medicine with advanced diagnostics, including metabolomics and genetics, to better understand complex neurological and systemic conditions.
Dr. Wallace has a strong clinical interest in neurodevelopmental conditions, including Autism Spectrum Disorder (ASD) and PANS/PANDAS, as well as immune and inflammatory contributors to neurological dysfunction.
She also works with adults seeking cognitive optimization and support through EEG-guided neuromodulation and lifestyle-based interventions.
Her research background includes publications on nutritional deficiencies, metabolomics, and functional medicine protocols, with contributions to peer-reviewed medical literature.
At Brain Treatment Center Michigan, Dr. Wallace oversees clinical evaluations, treatment planning, and ongoing medical supervision to ensure that MeRT protocols are delivered safely, appropriately, and in accordance with each patient’s neurological profile.
Dr. Lori Zettell is a board-certified physician with extensive clinical experience and advanced training in Functional Medicine and neuromodulation.
Dr. Zettell brings a comprehensive, data-driven approach to patient care, focusing on identifying the underlying causes of neurological and cognitive symptoms.
Her clinical background includes treating complex, chronic conditions and supporting patients through personalized, non-invasive treatment strategies.
At Brain Treatment Center Michigan, Dr. Zettell contributes to patient evaluation and treatment oversight, ensuring care is grounded in both clinical experience and emerging research.
Nathaniel Dickman is a 24-year United States Air Force veteran and Managing Director of Brain Treatment Center Michigan. He brings decades of leadership experience, operational oversight, and a strong commitment to serving the veteran community.
As Managing Director, Mr. Dickman oversees clinic operations and supports the delivery of high-quality, patient-focused care. His background in military service informs the clinic’s dedication to serving veterans and their families with professionalism, respect, and integrity.
Choosing a neurological treatment can feel overwhelming. Our New Patient Coordinator is available to answer questions, explain the MeRT process, review costs and protocols, and help determine next steps.
Support includes:
Explaining EEG testing and treatment planning
Discussing conditions treated with MeRT
Reviewing scheduling and consultation options
Answering insurance-related questions
Our goal is to ensure you have clear, accurate information so you can make an informed decision about whether MeRT is right for you or your loved one.
Repetitive transcranial magnetic stimulation (rTMS), the technology used in the MeRT process, is FDA-cleared to treat Major Depressive Disorder and Obsessive-Compulsive Disorder (OCD). Depending on your diagnosis and insurance plan, some coverage may be available for rTMS-based treatment.
Our team can help review potential insurance options and discuss payment considerations. Please note that Medicare and Medicaid do not currently cover MeRT or TMS treatment.
Or fill out the contact form below.
"*" indicates required fields